ICZOOM Sets a 5-for-1 Consolidation for Sept. 15, Twenty Sessions Before Its Oct. 12 Nasdaq Deadline

by Renée Delacroix · September 11, 2026

Senior Analyst, The MicroCap Herald

ICZOOM Group Inc. (Nasdaq: IZM) said Friday it will effect a 5-for-1 consolidation of its ordinary shares with a marketplace effective date of Sept. 15, 2026 -- a Tuesday -- a step taken expressly to restore compliance with Nasdaq's $1.00 minimum bid price requirement. The announcement was issued through GlobeNewswire and furnished to the Securities and Exchange Commission as an exhibit to a current report for a foreign private issuer.

The rule at issue is Nasdaq Marketplace Rule 5550(a)(2), the $1.00 minimum bid price provision that governs continued listing on the Nasdaq Capital Market. It is the rule named in Friday's exhibit, and it is the rule the Oct. 12 deadline attaches to -- not Rule 5550(b), the separate stockholders' equity, market value of listed securities and net income standard, which carries its own distinct cure path and is not at issue here. ICZOOM disclosed its bid-price deficiency on April 14, 2026, saying Nasdaq had notified it the previous day, April 13, and that it had 180 calendar days to regain compliance, until Oct. 12, 2026. (One hundred eighty calendar days from April 13 falls on Saturday, Oct. 10; the stated deadline is the following Monday.)

Tuesday's action therefore lands with roughly four weeks left on the original clock, and that timing is the central fact of this story. Compliance under Rule 5550(a)(2) is not achieved by a single close above a dollar; it requires a closing bid of at least $1.00 for a minimum of ten consecutive business days. Counting forward from Sept. 15, there are twenty trading sessions to Oct. 12, which means the qualifying streak must begin by about Sept. 29 and run without a single interruption.

The mechanics of the consolidation are set out precisely. Per the exhibit, Class A ordinary shares go from 8,188,610 to approximately 1,637,722, and Class B ordinary shares from 3,829,500 to approximately 765,900 -- a combined count falling from about 12.02 million to roughly 2.40 million. Both stated post-consolidation figures are the exact quotients of a division by five. The shares will continue to trade under the symbol IZM, and a new CUSIP, G4760B118, takes effect with the consolidation.

Fractional entitlements are rounded up rather than cashed out. The exhibit states that "no fractional shares will be issued to any shareholders in connection with the share consolidation, and each shareholder will be entitled to receive one share of the Company in lieu of the fractional share of that class that would have resulted from the share consolidation." That treatment is holder-friendly at the margin, and it is why the company states its post-consolidation counts as approximations: per-holder round-ups will push the actual totals somewhat above the clean quotients quoted above. The exhibit does not quantify that excess, and neither will this desk.

The valuation arithmetic is where the thin margin becomes visible -- with an important caveat about the vintage of the quote. StockAnalysis.com listed IZM at $0.2330 as of the Sept. 4 close, within a 52-week range of $0.2260 to $2.7300. That is the most recent price this desk could verify, and it is a week stale; the stock may have moved since. Mechanically, a 5-for-1 consolidation applied to $0.2330 implies a post-consolidation reference price of $1.165. That clears the $1.00 threshold by about sixteen and a half cents, or roughly sixteen percent -- a buffer that a few sessions of ordinary drift in a stock this small could erase before the ten-day streak completes.

A consolidation changes the denominator, not the business. It creates no new cash, retires no obligation, and leaves each holder's proportionate economic interest unchanged apart from the round-up. Post-split price decay is a well-documented pattern among thinly traded issuers, and nothing in Friday's disclosure commits the company to any measure -- a buyback, an insider purchase, a capital raise -- that would independently support the price during the compliance window. Holders should also note what the consolidation does not foreclose: it does not restrict the company from issuing new shares afterwards, and any subsequent equity raise at a depressed price would dilute them on the reduced base.

If the streak is not achieved by Oct. 12, ICZOOM's own April disclosure sets out what may come next. The company said then that it "may be eligible for an additional 180 calendar days, should the Company meet the continued listing requirement for market value of publicly held shares and all other initial listing standards for The Nasdaq Capital Market, with the exception of the bid price requirement, and is able to provide written notice of its intention to cure the deficiency during the second compliance period, by effecting a reverse stock split, if necessary." A second period is conditional, not automatic. Friday's exhibit does not say whether the company would seek one, and this desk is not asserting that effecting the consolidation now forecloses it. If neither period produces a cure, the shares become subject to delisting.

The market value of publicly held shares test deserves emphasis, and also deserves not to be conflated with market capitalization. StockAnalysis.com put ICZOOM's total market capitalization at approximately $2.80 million, on 12.02 million shares; StockTitan put the float at roughly 7.77 million shares. Market value of publicly held shares is measured against the public float, not the whole register, so it is a smaller number than the market cap -- and neither aggregator publishes the figure Nasdaq would test. A consolidation moves neither: it changes the share count and the nominal quote in offsetting directions. This desk is not asserting which standard would or would not be met.

The operating picture is unusual for a company at this valuation. StockAnalysis.com listed trailing-twelve-month revenue of $187.05 million, up 5.1 percent, with net income of $1.19 million, earnings per share of $0.10 and a price-to-earnings ratio of 2.41, on 12.02 million shares outstanding and 97 employees. Those are aggregator figures rather than filed statements, and readers should weigh them accordingly; this desk did not open the company's financial statements for this report and makes no claim about its cash, its debt or any other balance-sheet position.

What the business does is described in the exhibit itself: ICZOOM "is primarily engaged in sales of electronic component products to customers in Hong Kong and mainland China through its B2B e-commerce platform," a platform the exhibit says is "primarily used by China based small and medium-sized enterprises" in the consumer electronic industry, the Internet of Things, automotive electronics and industry control segments. It is a distribution model, which is consistent with high revenue against thin margins -- a structure that produces large top-line numbers and modest profits.

Two structural features are worth flagging without over-reading them. ICZOOM maintains two classes of ordinary shares, both of which are being consolidated at the same 5-for-1 ratio; Friday's disclosure does not restate the voting terms of either class, names no control block, describes no irrevocable proxy, and identifies no founder or officer as holding one. This desk is therefore not characterizing where voting control sits. Separately, the Class B count of 3,829,500 shares is a meaningful portion of the 12.02 million pre-consolidation register, and is broadly consistent with the roughly 4.25 million share gap between that total and StockTitan's 7.77 million float -- a point about how much of the register is genuinely publicly held, not about who votes it.

Friday's release contains no going-concern statement and no going-concern conclusion, no executive quotation, and no discussion of liquidity, cash or indebtedness. It is a procedural notice of a corporate action with a fixed effective date and a named regulatory purpose.

The measurable checkpoints from here are Tuesday's opening quote under the new CUSIP, whether the closing bid holds at or above $1.00 beginning in the last days of September, and the Oct. 12 expiry of the original compliance period. None of those outcomes is assured, failure at both the first and any second compliance period would put the listing at risk, and the company has not asserted otherwise. Nothing in this report is investment advice.